Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A re-engineered immunotoxin shows promising preclinical activity in ovarian cancer.
Sci Rep. 2017 Dec 22;7(1):18086. doi: 10.1038/s41598-017-17329-7.
Sci Rep. 2017.
PMID: 29273809
Free PMC article.
Molecular characterization of novel trispecific ErbB-cMet-IGF1R antibodies and their antigen-binding properties.
Castoldi R, Jucknischke U, Pradel LP, Arnold E, Klein C, Scheiblich S, Niederfellner G, Sustmann C.
Castoldi R, et al. Among authors: scheiblich s.
Protein Eng Des Sel. 2012 Oct;25(10):551-9. doi: 10.1093/protein/gzs048. Epub 2012 Aug 29.
Protein Eng Des Sel. 2012.
PMID: 22936109
Free PMC article.
Item in Clipboard
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, Jones T, Jucknischke U, Scheiblich S, Kaluza K, Gorr IH, Walz A, Abiraj K, Cassier PA, Sica A, Gomez-Roca C, de Visser KE, Italiano A, Le Tourneau C, Delord JP, Levitsky H, Blay JY, Rüttinger D.
Ries CH, et al. Among authors: scheiblich s.
Cancer Cell. 2014 Jun 16;25(6):846-59. doi: 10.1016/j.ccr.2014.05.016. Epub 2014 Jun 2.
Cancer Cell. 2014.
PMID: 24898549
Free article.
Item in Clipboard
Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains.
Kienast Y, Jucknischke U, Scheiblich S, Thier M, de Wouters M, Haas A, Lehmann C, Brand V, Bernicke D, Honold K, Lorenz S.
Kienast Y, et al. Among authors: scheiblich s.
J Biol Chem. 2016 Feb 12;291(7):3395-410. doi: 10.1074/jbc.M115.680009. Epub 2015 Dec 16.
J Biol Chem. 2016.
PMID: 26677222
Free PMC article.
Item in Clipboard
Crystal structures of active SRC kinase domain complexes.
Breitenlechner CB, Kairies NA, Honold K, Scheiblich S, Koll H, Greiter E, Koch S, Schäfer W, Huber R, Engh RA.
Breitenlechner CB, et al. Among authors: scheiblich s.
J Mol Biol. 2005 Oct 21;353(2):222-31. doi: 10.1016/j.jmb.2005.08.023.
J Mol Biol. 2005.
PMID: 16168436
Item in Clipboard
Quantitative chemical proteomics profiling differentiates erlotinib from gefitinib in EGFR wild-type non-small cell lung carcinoma cell lines.
Augustin A, Lamerz J, Meistermann H, Golling S, Scheiblich S, Hermann JC, Duchateau-Nguyen G, Tzouros M, Avila DW, Langen H, Essioux L, Klughammer B.
Augustin A, et al. Among authors: scheiblich s.
Mol Cancer Ther. 2013 Apr;12(4):520-9. doi: 10.1158/1535-7163.MCT-12-0880. Epub 2013 Jan 31.
Mol Cancer Ther. 2013.
PMID: 23371860
Item in Clipboard
Cite
Cite